Wall Street Associates »

Enanta Pharmaceuticals shares owned by Wall Street Associates

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Wall Street Associates from 13F filings

Historical chart of Wall Street Associates investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Wall Street Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Wall Street Associates

Quarter filed Position value Share count Share price at filing
2013-03-31 $4.6M 250k 18.20

More positions owned by Wall Street Associates

Quidel Corporation
Gtt Communications
Retrophin
Carriage Services (CSV)
Tactile Systems Technology, In (TCMD)
Instructure
Boingo Wireless
Vocera Communications
Del Taco Restaurants
Hannon Armstrong (HASI)
Amber Road
Q2 Holdings (QTWO)
Mimecast
Nautilus (BFXXQ)
Alarm Com Hldgs (ALRM)

View all positions for Wall Street Associates

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Vanguard Group
BlackRock
Krensavage Asset Management
Armistice Capital
Marshall Wace
Acadian Asset Management
Soleus Capital Management
Millennium Management
Bank of America Corporation
Citadel Advisors
Northern Trust
Renaissance Technologies
D. E. Shaw & Co
Geode Capital Management

View all funds holding Enanta Pharmaceuticals